Consider the Role of Semaglutide for Chronic Kidney Disease

November 2024

You’ll hear buzz about semaglutide for chronic kidney disease (CKD).

We know that some injectable GLP-1 agonists (dulaglutide, liraglutide, semaglutide) may slow CKD progression.

But previous studies either didn’t focus on CKD and diabetes together...or benefits in CKD were only secondary outcomes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote